SCHEMBL424107

SCHEMBL424107

CCCCCCCC/C=C\CCCCCCCCCCC(CCC(CCCCCCCCCC/C=C\CCCCCCCC)C(N)=O)C(N)=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.59
SOAT1 P35610 2/20 0.59
CYP1A2 P05177 2/20 0.59
CYP2C19 P33261 2/20 0.59
KMT2A Q03164 2/20 0.59
MEN1 O00255 1/20 0.59
TP53 P04637 1/20 0.59
CYP3A4 P08684 1/20 0.59
KDM4E B2RXH2 2/20 0.54
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CNR1 P21554 1/20 0.51
TERT O14746 3/20 0.50
PTPN1 P18031 3/20 0.50
MAPT P10636 2/20 0.50
BLM P54132 2/20 0.50
HSD17B10 Q99714 2/20 0.50
FABP4 P15090 2/20 0.50
PPARG P37231 2/20 0.50
PPARD Q03181 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL303222 1.00 FAAH (0.59) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL6282579 0.98 FAAH (0.61) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL6903528 0.98 FAAH (0.61) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL3375129 0.98 FAAH (0.61) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL195339 0.98 FAAH (0.61) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL10488433 0.98 FAAH (0.61) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL195336 0.98 FAAH (0.61) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL376319 0.98 FAAH (0.61) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL11786448 0.98 FAAH (0.61) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL933317 0.98 FAAH (0.61) FAAHSOAT1CYP1A2CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717755-A1 GRANULES FOR GRANULE DISHWASHER Kaneka Belgium N.V. (BE) 2026-04-01 EP claimed
EP-3434251-B1 DRUG CONTAINER TERUMO CORP (JP) 2023-08-16 EP claimed
WO-2022259547-A1 LUBRICANT, COMBINATION OF LUBRICANTS, POWDER MIXTURE, COMBINATION OF RAW MATERIALS FOR POWDER MIXTURE AND PRODUCTION METHOD FOR SINTERED BODY 昭和電工マテリアルズ株式会社 2022-12-15 WO claimed
WO-2022260009-A1 LUBRICANT, COMBINATION OF LUBRICANTS, POWDER MIXTURE, COMBINATION OF RAW MATERIALS FOR POWDER MIXTURE AND PRODUCTION METHOD FOR SINTERED BODY 昭和電工マテリアルズ株式会社 2022-12-15 WO claimed
WO-2022259548-A1 COMBINATION OF LUBRICANTS, POWDER MIXTURE, COMBINATION OF RAW MATERIALS FOR POWDER MIXTURE AND PRODUCTION METHOD FOR SINTERED BODY 昭和電工マテリアルズ株式会社 2022-12-15 WO claimed
US-11077252-B2 Drug container TERUMO KABUSHIKI KAISHA (JP) 2021-08-03 US claimed
EP-3434251-A1 DRUG CONTAINER Terumo Kabushiki Kaisha (JP) 2019-01-30 EP claimed
US-20190022325-A1 DRUG CONTAINER TERUMO KABUSHIKI KAISHA (JP) 2019-01-24 US claimed
US-8465665-B2 Refrigerating-machine oil composition, and compressor for refrigerating machine and refrigerating apparatus each employing the same IDEMITSU KOSAN CO., LTD. (JP) 2013-06-18 US claimed
US-20110252825-A1 REFRIGERATING-MACHINE OIL COMPOSITION, AND COMPRESSOR FOR REFRIGERATING MACHINE AND REFRIGERATING APPARATUS EACH EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-10-20 US claimed
US-4579696-A ETHLENE-VINYL ACETATE CORE WITH ETHYLENE POLYMER EXTERIOR E. I. DUPONT DE NEMOURS AND COMPANY (US) 1986-04-01 US claimed
US-4524099-A ETHYLENE-VINYL ACETATE CORE, AND POLYETHYLENE OR ETHYLENE WITH ALPHA-OLEFIN OR VINYL ACETATE COPOLYMER EXTERIORS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-06-18 US claimed
EP-0120052-A4 COEXTRUDED ELASTOMERIC FILMS. DU PONT (US) 1985-03-08 EP claimed
EP-0120052-A1 COEXTRUDED ELASTOMERIC FILMS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1984-10-03 EP claimed
WO-1984001327-A1 COEXTRUDED ELASTOMERIC FILMS DU PONT (US) 1984-04-12 WO claimed
US-12612488-B2 Resin composition for injection molding and injection-molded article KANEKA CORPORATION (JP) 2026-04-28 US disclosed
US-20260109105-A1 METHOD FOR PRODUCING STRETCHED FILM KANEKA CORPORATION (JP) 2026-04-23 US disclosed
EP-0120052-A1 COEXTRUDED ELASTOMERIC FILMS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1984-10-03 EP disclosed
WO-1984001327-A1 COEXTRUDED ELASTOMERIC FILMS DU PONT (US) 1984-04-12 WO disclosed
EP-0068148-A2 Tack-free polymer pellets E.I. DU PONT DE NEMOURS AND COMPANY (US) 1983-01-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109105-A1 METHOD FOR PRODUCING STRETCHED FILM TPM3, TPM4, HACD3 FAAH 858/4885SOAT1 1979/4885CYP1A2 3963/4885
US-12612488-B2 Resin composition for injection molding and injection-molded article HACD3, FGB, HACL2 FAAH 964/4885SOAT1 2125/4885CYP1A2 2351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.